Cabot Wealth Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-967
Closed -$238K 158
2022
Q3
$238K Hold
967
0.04% 140
2022
Q2
$239K Hold
967
0.04% 139
2022
Q1
$320K Sell
967
-200
-17% -$61.6K 0.04% 136
2021
Q4
$419K Hold
1,167
0.05% 129
2021
Q3
$380K Sell
1,167
-100
-8% -$33.9K 0.05% 125
2021
Q2
$395K Hold
1,267
0.05% 123
2021
Q1
$404K Hold
1,267
0.06% 119
2020
Q4
$411K Sell
1,267
-87
-6% -$24.1K 0.06% 110
2020
Q3
$375K Sell
1,354
-160
-11% -$46.1K 0.07% 105
2020
Q2
$365K Sell
1,514
-25
-2% -$5.02K 0.07% 104
2020
Q1
$223K Hold
1,539
0.05% 110
2019
Q4
$263K Sell
1,539
-50
-3% -$9.27K 0.05% 113
2019
Q3
$283K Hold
1,589
0.06% 114
2019
Q2
$414K Sell
1,589
-87
-5% -$23.1K 0.09% 97
2019
Q1
$479K Hold
1,676
0.11% 93
2018
Q4
$545K Sell
1,676
-2,479
-60% -$861K 0.13% 92
2018
Q3
$1.87M Buy
4,155
+1,929
+87% +$760K 0.4% 67
2018
Q2
$911K Hold
2,226
0.2% 81
2018
Q1
$648K Hold
2,226
0.14% 85
2017
Q4
$417K Hold
2,226
0.09% 100
2017
Q3
$375K Hold
2,226
0.08% 101
2017
Q2
$319K Hold
2,226
0.07% 112
2017
Q1
$279K Hold
2,226
0.07% 119
2016
Q4
$251K Hold
2,226
0.07% 131
2016
Q3
$286K Hold
2,226
0.07% 126
2016
Q2
$243K Hold
2,226
0.06% 132
2016
Q1
$211K Sell
2,226
-100
-4% -$8.44K 0.06% 133
2015
Q4
$210K Hold
2,326
0.05% 138
2015
Q3
$216K Buy
+2,326
New +$205K 0.06% 131

Other funds holding ABMD

Cabot Wealth Management's ABMD Position: Q4 2022 in Review

Cabot Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 967 shares — an estimated $238K sold.

Cabot Wealth Management first reported a position in ABMD in Q3 2015 and held it in 29 quarters. The position peaked at $1.87M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Cabot Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Cabot Wealth Management sold 967 Abiomed Inc shares in Q4 2022, an estimated $238K.
  • Cabot Wealth Management first reported a position in Abiomed Inc in Q3 2015 and held it in 29 quarters.
  • Cabot Wealth Management's Abiomed Inc position peaked at $1.87M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Cabot Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.